News

51% of the overall gastrointestinal therapeutic pipeline is in Phase II to Phase III development, of which 19 molecules are indicated for the treatment of Irritable Bowel Syndrome, 48 for ulcerative colitis, and 41 for Chron?s Disease.

Company News Release

The Association of Clinical Research Professionals (ACRP) has learned that TransCelerate Biopharma, Inc., now recognizes certification through the Certified Clinical Research Coordinator (CCRC?) and Certified Physician Investigator (CPI?) programs of ACRP's affiliate, the Academy of Clinical Research Professionals (the Academy), as evidence of Good Clinical Practice (GCP) training.

clintech-832194-1408528650735.jpeg

IMS Health Files for IPO

Applied Clinical Trials

IMS Health has filed a registration statement with the US Securities and Exchange Commission